FHS investigator Michelle Long, MD announced as Doris Duke 2019 Clinical Scientist Development Awardee

Michelle Long, MD, MSc, Assistant Professor of medicine, has been awarded a three-year, $495,000 Doris Duke Clinical Scientist Development Award from the Doris Duke Charitable Foundation.
The Doris Duke Clinical Scientist Development Award provides grants to early-career physician scientists to facilitate their transition to independent clinical research careers. Dr. Long, an Assistant Professor of Medicine at Boston University School of Medicine (BUSM) and a gastroenterologist at Boston Medical Center (BMC), was one of 16 funded investigators out of 210 applicants.
Dr. Long will use her award to further her research on hepatic fibrosis in Non-Alcoholic Fatty Liver Disease (NAFLD). NAFLD affects nearly 40 percent of Americans and represents a spectrum of liver disease that occurs in the absence of excessive alcohol use, including an accumulation of fat in the liver (hepatic steatosis) and a progression of excess scar tissue (hepatic fibrosis).
In her previous studies, Dr. Long has measured the association between NAFLD and physical activity; NAFLD and sub-clinical measures of cardiovascular disease (CVD); and clinical and genetic traits associated with NAFLD-associated hepatic fibrosis among participants of the Framingham Heart Study (FHS).
Read more from the Boston University School of Medicine
Doris Duke Charitable Foundation Announcement